Earnings Call · Q1 FY2025·2025-05-19

Q1 25EPS +53.61%·Rev n/aQ4 24EPS -88.89%·Rev n/aQ3 24EPS +27.14%·Rev n/aQ2 24EPS -33.33%·Rev n/a⚠ consensus missing

BRAINSTORM CELL THERAPEUTICS INC. BCLI

Joyce Lonergan — Investor Relations

Chaim Lebovits — Chief Executive Officer

Haro Hartounian — Chief Operating Officer

Bob Dagher — Chief Medical Officer

Netta Blondheim-Shraga — Senior Scientist or Researcher

+13.8%1d on move date+13.2% vs SPY3d+6.9%5d−4.3%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BCLI calls or request research access.

More BCLI calls Browse calls Request research access